Suppr超能文献

体外和体内启动子活性的生物发光监测

Bioluminescence Monitoring of Promoter Activity In Vitro and In Vivo.

作者信息

Delhove Juliette M K M, Karda Rajvinder, Hawkins Kate E, FitzPatrick Lorna M, Waddington Simon N, McKay Tristan R

机构信息

Cardiovascular and Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London, SW17 0RE2, UK.

Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

出版信息

Methods Mol Biol. 2017;1651:49-64. doi: 10.1007/978-1-4939-7223-4_5.

Abstract

The application of luciferase reporter genes to provide quantitative outputs for the activation of promoters is a well-established technique in molecular biology. Luciferase catalyzes an enzymatic reaction, which in the presence of the substrate luciferin produces photons of light relative to its molar concentration. The luciferase transgene can be genetically inserted at the first intron of a target gene to act as a surrogate for the gene's endogenous expression in cells and transgenic mice. Alternatively, promoter sequences can be excised and/or amplified from genomic sources or constructed de novo and cloned upstream of luciferase in an expression cassette transfected into cells. More recently, the development of synthetic promoters where the essential components of an RNA polymerase binding site and transcriptional start site are fused with various upstream regulatory sequences are being applied to drive reporter gene expression. We have developed a high-throughput cloning strategy to develop lentiviral luciferase reporters driven by transcription factor activated synthetic promoters. Lentiviruses integrate their payload cassette into the host cell genome, thereby facilitating the study of gene expression not only in the transduced cells but also within all subsequent daughter cells. In this manuscript we describe the design, vector construction, lentiviral transduction, and luciferase quantitation of transcription factor activated reporters (TFARs) in vitro and in vivo.

摘要

在分子生物学中,应用荧光素酶报告基因来定量输出启动子的激活情况是一项成熟的技术。荧光素酶催化一种酶促反应,在底物荧光素存在的情况下,根据其摩尔浓度产生光子。荧光素酶转基因可以通过基因插入到靶基因的第一个内含子中,作为该基因在细胞和转基因小鼠中内源性表达的替代物。或者,可以从基因组来源切除和/或扩增启动子序列,或从头构建并克隆到转染到细胞中的表达盒中荧光素酶的上游。最近,将RNA聚合酶结合位点和转录起始位点的基本成分与各种上游调控序列融合的合成启动子的开发正被用于驱动报告基因表达。我们开发了一种高通量克隆策略,以开发由转录因子激活的合成启动子驱动的慢病毒荧光素酶报告基因。慢病毒将其有效载荷盒整合到宿主细胞基因组中,从而不仅便于在转导细胞中,而且在所有后续子代细胞中研究基因表达。在本手稿中,我们描述了体外和体内转录因子激活报告基因(TFARs)的设计、载体构建、慢病毒转导和荧光素酶定量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验